
Join us for the Newsweek AI Health Summit
New York City | September 23, 2026
AI Health Summit: Driving Outcomes and Reducing Risk
Artificial intelligence is starting to enable what American healthcare has long hoped to achieve: faster diagnoses, more personalized treatment and fewer operational and administrative hurdles. Yet despite its early impact, value remains uneven and difficult to scale.
To bridge this gap, hospital leaders must move beyond isolated pilots toward system-wide AI deployment. This requires a fundamental shift in strategy: modernizing legacy infrastructure, establishing risk-based governance frameworks that empower clinicians rather than bypass them, and navigating a complex regulatory "patchwork"--250 state-level AI bills were introduced in 2025 alone, with 33 enacted across 21 states.
How can health system leaders close the AI implementation gap while managing risk and earning clinical trust? What do landmark partnerships such as that between Nvidia and Eli Lilly’s Co-Innovation lab mean for advancing drug discovery, and moving towards more effective and personalized treatments?
Join Newsweek and Investment Reports for the AI Health Summit in New York City on September 23rd to learn how leading organizations are turning AI experimentation into impact.
Join Us!
Join Newsweek during AI Health Summit for insightful discussions and innovative solutions.
Ticket Price |
$999 |
The Venue
Partners

BD is one of the world’s largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare.

Fueled by our bold purpose to improve the health of humanity, we are transforming from a traditional health benefits organization into a lifetime trusted health partner. Our nearly 100,000 associates serve approximately 100M+ people, at every stage of health. We address a full range of needs with an integrated whole health approach, powered by industry-leading capabilities and a digital platform for health.

King Faisal Specialist Hospital & Research Centre in Riyadh is a major Saudi academic medical centre focused on specialized and complex care. It combines clinical services with education and research, with strengths across areas such as oncology, organ transplantation, cardiac care, genomics, surgery and neurosciences.

We give everything our all—because everything we do has the potential to change lives. We are a global life sciences and healthcare company harnessing science for human good. Every day, our mission is to improve health and improve lives.

Nabla was founded by leaders in artificial intelligence and healthcare technology and operates across two global hubs for innovation: Paris and New York. Our team brings together world-class engineers, clinicians, and healthcare operators building the infrastructure that will power the next generation of clinical care.

Founded by doctors and guided by deep clinical, operational, and technical expertise, we help health systems and physician organizations deliver better outcomes, lower costs, and a better experience for patients and providers. Today, we’re combining our legacy of success with the power of AI to pioneer Primary Care as a Service (PCaaS)—expanding access, reducing burden, and making it easier for physicians to focus on what matters most: caring for people.
Audience & Reach






Moderators

Jennifer Cunningham
Editor in Chief
Newsweek

Alexis Kayser
Health Care Editor
Newsweek
Speakers

Dr. Brendan Carr
CEO
Mount Sinai Health System


Dr. Sophie J. Bakri
Medical Director, Center for Digital Health
Chair, Department of Ophthalmology
Whitney and Betty MacMillan Professor of Ophthalmology in Honor of Robert R. Waller, M.D., Mayo Clinic


Dr. Björn Zoéga
CEO
King Faisal Specialist Hospital & Research Centre


Dr. Ashley Beecy
Chief AI Officer
Sutter Health


Rohit Chandra
Executive Vice President and Chief Digital Officer
Cleveland Clinic


Dr. David Carmouche
Chief Medical and Commercial Officer
Lumeris


John Couris
President & CEO
Florida Health Sciences Center (FHSC) and Tampa General Hospital


Ratnakar Lavu
Chief Digital Information Officer
Elevance Health


Jennifer Litton
Chief Clinical Research Officer and Professor, Breast Medical Oncology
The University of Texas MD Anderson Cancer Center

Bilal Muhsin
EVP and President, Connected Care Segment
BD


Bola Oyegunwa
EVP, Chief Information and Technology Officer
Labcorp


Philip Payne
Chief Health AI Officer
BJC Health and WashU Medicine


Dr. Matt Sakumoto
Chief Clinical Product Officer
Nabla


Luis E. Taveras
Executive Vice President, Chief Digital and Information Officer
Jefferson Health


Theo Zanos
Professor, Head - Division of Health AI, Head - Neural and Data Science Lab
Northwell Health

Agenda
| 8:15 AM – 9:15 AM |
Registration & Breakfast
|
| 9:15 AM – 9:20 AM |
Opening Remarks
|
| 9:20 AM – 9:40 AM |
Keynote Interview. From System Opportunity to Patient Advantage: How AI will Transform Healthcare
|
| 9:40 AM – 10:25 AM |
Panel. Hospitals Reimagined
Where are organizations realizing ROI and improved outcomes with AI? What is driving investment, and how will hospital care evolve in the next 1-2 years? This session draws on themes from “Hospitals Reimagined”, a report launched this week. |
| 10:25 AM – 10:55 AM |
Interview. 250+ State AI Bills: What Multi-State Health Systems Need to Watch
As regulators try to catch up to the pace of innovation, the compliance landscape is becoming more fragmented and unpredictable. What are the risks, and how should health systems and innovators plan for an environment where the rules are still being written? |
| 10:55 AM – 11:20 AM |
Networking Break
|
| 11:20 AM – 11:45 AM |
Case Study. Operationalizing AI in Hospitals
|
| 11:45 AM – 12:30 PM |
Panel. AI-Enabled Clinicians: Trust, Accountability and Decision-Making
How do clinicians engage with AI in practice, and where does accountability sit when decisions are informed–or challenged–by algorithms? How do they maintain transparency and reassurance for patients? |
| 12:30 PM – 1:30 PM |
Lunch & Networking
|
| 1:30 PM – 2:15 PM |
Panel. Transforming Drug Discovery, Development and Access
AI is accelerating drug discovery, improving the efficiency of clinical trials and reshaping access strategies. Where are the biggest opportunities, and what are the greatest bottlenecks? |
| 2:15 PM – 3:00 PM |
Panel. Out-of-Hospital Care: Reshaping Prevention, Intervention and Patient Engagement
From hospital-at-home models to continuous monitoring, care delivery is becoming more distributed. What does this mean for system design, capacity planning and the role of acute care? |
| 3:00 PM – 3:30 PM |
Networking Break
|
| 3:30 PM – 4:10 PM |
Panel. Preventing Harm: Governance, Risk and Patient Safety
As health systems become more reliant on digital infrastructure, data and AI, the definition of patient safety is expanding. How can leaders build governance frameworks that identify and manage emerging risks, protect against cyber threats and system vulnerabilities, and ensure new technologies are deployed safely and responsibly?
|
| 4:10 PM – 4:55 PM |
Panel. AI in Health 2030: Opportunity, Constraint and Scale
Which technologies will deliver system-level impact, and how will they transform care delivery? What will define success over the next five years? |
| 4:55 PM – 5:00 PM |
Closing Remarks
|
| 5:00 PM – 6:00 PM |
Networking Reception
|
If you have a question you would like to ask related to one of our panel discussions, please email us at events@newsweek.com and we will do our very best to have this included in the conversation.
Past Attendees
















Industry Partner

Speak to us about sponsorship and brand opportunities
Partner with us to deliver your message directly to our audience, boost your visibility and grow your reputation.
